{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T07:01:13Z","timestamp":1784962873741,"version":"3.55.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"there is no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biopharmaceutical Statistics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1080\/10543406.2024.2330211","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T07:31:36Z","timestamp":1711697496000},"page":"1007-1025","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Flexible seamless 2-in-1 design with sample size adaptation"],"prefix":"10.1080","volume":"34","author":[{"given":"Runjia","family":"Li","sequence":"first","affiliation":[{"name":"Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-3794","authenticated-orcid":false,"given":"Liwen","family":"Wu","sequence":"additional","affiliation":[{"name":"Statistical and Quantitative Sciences, Takeda Pharmaceuticals, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Liu","sequence":"additional","affiliation":[{"name":"Statistical and Quantitative Sciences, Takeda Pharmaceuticals, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchang","family":"Lin","sequence":"additional","affiliation":[{"name":"Statistical and Quantitative Sciences, Takeda Pharmaceuticals, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs180"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2019.1633656"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2180"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533441"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2017.09.006"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1688"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.107047"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.00853.x"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2019.1634088"},{"key":"e_1_3_4_11_1","unstructured":"FDA (2014) \u201cGuidance for industry expedited programs for serious conditions \u2013 drugs and biologics.\u201d"},{"key":"e_1_3_4_12_1","unstructured":"FDA (2019) \u201cAdaptive designs for clinical trials of drugs and biologics - guidance for industry.\u201d"},{"key":"e_1_3_4_13_1","unstructured":"FDA (2020) \u201cAccelerated Approval Program.\u201d"},{"key":"e_1_3_4_14_1","unstructured":"FDA (2022a) \u201cExpansion cohorts: Use in first-in-human clinical trials to expedite development of oncology drugs and biologics.\u201d"},{"key":"e_1_3_4_15_1","unstructured":"FDA (2022b) \u201cProject FrontRunner \u2013 advancing development of new oncology therapies to the early clinical setting.\u201d"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2641"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201900020"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543400802369053"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106096"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2021.1938203"},{"key":"e_1_3_4_21_1","unstructured":"Liu A. 2022. FDA oncology chief aims to open up accelerated approval for earlier cancer treatment under \u2018project FrontRunner\u2019. Fierce Biotech 6 April. https:\/\/www.fiercebiotech.com\/biotech\/fdaoncology-chief-eyes-accelerated-approval-earlier-cancer-treatmentunder-planned-project."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9863"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5738"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4102"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533262"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12524"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2022.2046150"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2022.2080693"}],"updated-by":[{"DOI":"10.1080\/10543406.2024.2428565","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000}}],"container-title":["Journal of Biopharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2024.2330211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T13:59:44Z","timestamp":1732802384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2024.2330211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1080\/10543406.2024.2330211"],"URL":"https:\/\/doi.org\/10.1080\/10543406.2024.2330211","relation":{"correction":[{"id-type":"doi","id":"10.1080\/10543406.2024.2428565","asserted-by":"object"}]},"ISSN":["1054-3406","1520-5711"],"issn-type":[{"value":"1054-3406","type":"print"},{"value":"1520-5711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}